Insider · CIK 0001446372

Silva Paul M

CIK 0001446372 Name as filed on the most recent filing

Filed as Silva Paul M (106)

265 transaction lines · from 106 filings · filed 2008-11-19 to 2021-03-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

265 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2020-04-13 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 36,843, disposed Open Form 4 filing 0001209191-20-024476
2020-04-13 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 12,205, disposed Open Form 4 filing 0001209191-20-024476
2020-04-06 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 1,249,993, disposed Open Form 4 filing 0001209191-20-023914
2020-02-25 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 7 lines 252,127, disposed Open Form 4 filing 0001209191-20-013037
2020-02-18 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 5 lines 380,957, disposed Open Form 4 filing 0001209191-20-010554
2020-02-11 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 5 lines 1,442,301, disposed Open Form 4 filing 0001209191-20-008895
2020-02-06 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3 lines 111,523, disposed Open Form 4 filing 0001209191-20-007523
2020-02-03 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 5 lines 484,939, disposed Open Form 4 filing 0001209191-20-006959
2020-01-31 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 333,155, disposed Open Form 4 filing 0001209191-20-006304
2020-01-13 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 197,267, disposed Open Form 4 filing 0001209191-20-003458
2020-01-08 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3,188,488, disposed Open Form 4 filing 0001209191-20-003064
2020-01-02 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 4 lines 5,610,993, disposed Open Form 4 filing 0001209191-20-001770
2019-05-15 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 26,631, disposed Open Form 4 filing 0001209191-19-030950
2019-02-19 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3 lines 525,747, disposed Open Form 4 filing 0001209191-19-012010
2019-02-11 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 3 lines 759,367, disposed Open Form 4 filing 0001209191-19-009630
2019-02-06 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 248,777, disposed Open Form 4 filing 0001209191-19-008045
2019-02-04 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 5 lines 794,273, disposed Open Form 4 filing 0001209191-19-007770
2019-01-17 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 246,263, disposed Open Form 4 filing 0001209191-19-004552
2019-01-17 S, Open-market sale Vertex Pharmaceuticals Inc / MAVRTX 163,459, disposed Open Form 4 filing 0001209191-19-004552

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 265
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Silva Paul M, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001446372

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.